Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2922

1.

COVID-19.

Kim KH.

Int Neurourol J. 2020 Mar;24(1):1. doi: 10.5213/inj.2020edi.001. Epub 2020 Mar 30. No abstract available.

PMID:
32252179
2.

Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).

Park SE.

Clin Exp Pediatr. 2020 Apr 2. doi: 10.3345/cep.2020.00493. [Epub ahead of print]

PMID:
32252141
3.

Epidemiology and Clinical Features of Coronavirus disease 2019 in Children.

Choi SH, Kim HW, Kang JM, Kim DH, Cho EY.

Clin Exp Pediatr. 2020 Apr 6. doi: 10.3345/cep.2020.00535. [Epub ahead of print]

PMID:
32252139
4.

Annals Graphic Medicine - Morning Thoughts on Day 7 of COVID-19 Social Isolation.

Siegel J.

Ann Intern Med. 2020 Apr 7. doi: 10.7326/G20-0021. [Epub ahead of print] No abstract available.

PMID:
32252092
5.

Psychosomatic Medicine and Covid-19 Pandemic.

Joos A.

Psychother Psychosom. 2020 Apr 6:1-2. doi: 10.1159/000507640. [Epub ahead of print] No abstract available.

PMID:
32252058
6.

Interpreting COVID-19 and Virtual Care Trends: A Call for Action.

Khairat S, Meng C, Xu Y, Edson B, Gianforcaro R.

JMIR Public Health Surveill. 2020 Apr 5. doi: 10.2196/18811. [Epub ahead of print]

PMID:
32252023
7.

Acute leukemia in the time of COVID-19.

Gavillet M, Carr Klappert J, Spertini O, Blum S.

Leuk Res. 2020 Mar 26;92:106353. doi: 10.1016/j.leukres.2020.106353. [Epub ahead of print] No abstract available.

PMID:
32251934
8.

COVID 2019 outbreak: The disappointment in Indian teachers.

Bhat R, Singh VK, Naik N, Kamath CR, Mulimani P, Kulkarni N.

Asian J Psychiatr. 2020 Mar 28;50:102047. doi: 10.1016/j.ajp.2020.102047. [Epub ahead of print] No abstract available.

PMID:
32251853
9.

Residency and Fellowship Program Accreditation: Effects of the Novel Coronavirus (COVID-19) Pandemic.

Potts JR 3rd.

J Am Coll Surg. 2020 Apr 3. pii: S1072-7515(20)30299-4. doi: 10.1016/j.jamcollsurg.2020.03.026. [Epub ahead of print]

PMID:
32251848
10.

Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital.

Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, Ge L, Wang F, Chen Q, Zhang Y, Zhao Q.

Clin Microbiol Infect. 2020 Apr 3. pii: S1198-743X(20)30177-4. doi: 10.1016/j.cmi.2020.03.032. [Epub ahead of print]

PMID:
32251842
11.

Perspectives on Surgery in the time of COVID-19: Safety First.

Cohen SL, Liu G, Abrao M, Smart N, Heniford T.

J Minim Invasive Gynecol. 2020 Apr 3. pii: S1553-4650(20)30172-2. doi: 10.1016/j.jmig.2020.04.003. [Epub ahead of print] No abstract available.

PMID:
32251839
12.

Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China.

Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, Shen B, Gong Z.

Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30186-7. doi: 10.1016/j.ijid.2020.03.053. [Epub ahead of print]

PMID:
32251805
13.

Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019.

Jin Y, Wang M, Zuo Z, Fan C, Ye F, Cai Z, Wang Y, Cui H, Pan K, Xu A.

Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30198-3. doi: 10.1016/j.ijid.2020.03.065. [Epub ahead of print]

PMID:
32251798
14.

The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?

Mao ZQ, Wan R, He LY, Hu YC, Chen W.

Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30173-9. doi: 10.1016/j.ijid.2020.03.041. [Epub ahead of print]

PMID:
32251796
15.

Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?

Hong X, Xiong J, Feng Z, Shi Y.

Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30191-0. doi: 10.1016/j.ijid.2020.03.058. [Epub ahead of print]

PMID:
32251794
16.

A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2.

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S.

Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30195-8. doi: 10.1016/j.ijid.2020.03.062. [Epub ahead of print]

PMID:
32251791
17.

Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong.

Law S, Leung AW, Xu C.

Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30192-2. doi: 10.1016/j.ijid.2020.03.059. [Epub ahead of print] Review.

PMID:
32251790
18.

Spatial epidemic dynamics of the COVID-19 outbreak in China.

Kang D, Choi H, Kim JH, Choi J.

Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30209-5. doi: 10.1016/j.ijid.2020.03.076. [Epub ahead of print]

PMID:
32251789
19.

The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.

Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM.

Antiviral Res. 2020 Apr 3:104787. doi: 10.1016/j.antiviral.2020.104787. [Epub ahead of print]

PMID:
32251768
20.

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.

Choy KT, Yin-Lam Wong A, Kaewpreedee P, Sia SF, Chen D, Yan Hui KP, Wing Chu DK, Wai Chan MC, Pak-Hang Cheung P, Huang X, Peiris M, Yen HL.

Antiviral Res. 2020 Apr 3:104786. doi: 10.1016/j.antiviral.2020.104786. [Epub ahead of print]

PMID:
32251767

Supplemental Content

Loading ...
Support Center